Pediatrix Medical (MD) Liabilities and Shareholders Equity (2009 - 2026)

Pediatrix Medical has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $2.1 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 3.85% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $8.6 billion (up 4.87% YoY), while the FY2025 annual figure was $2.2 billion, up 4.37% from the prior year.
• Liabilities and Shareholders Equity retreated to $2.1 billion in Q1 2026, from $2.2 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for MD reached as high as $2.4 billion in Q2 2022 and fell as low as $2.0 billion in Q1 2025.
• The 5-year median for Liabilities and Shareholders Equity is $2.2 billion (2023), against an average of $2.2 billion.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 13.76% — and 2025, when it rose 5.9%.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.3 billion in 2022, then decreased by 5.45% to $2.2 billion in 2023, then slipped by 3.02% to $2.2 billion in 2024, then gained by 4.37% to $2.2 billion in 2025, then fell by 7.85% to $2.1 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.1 billion, $2.2 billion, and $2.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.